CS logo
small CS logo
University of Debrecen

Debrecen, Hungary
Egyetem, Debrecen

About University of Debrecen


A Debreceni Egyetem a Kossuth Lajos Tudományegyetem, a Debreceni Orvostudományi Egyetem, a Debreceni Agrártudományi Egyetem és a hajdúböszörményi Wargha István Pedagógiai Főiskola összevonásával jött létre 2000. január 1-jén.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Debrecen
4
AOP Orphan Pharmaceuticals AG
3
Aires Pharmaceuticals, Inc.
2
Incyte Corporation
2
Johns Hopkins University
2
Mayo Clinic
2
Medtronic Cardiac Rhythm and Heart Failure
2
Semmelweis University Heart and Vascular Center
2
Spectrum Pharmaceuticals, Inc
2
Actelion
1
Amsterdam UMC, location VUmc
1
Total Rows: 40

Clinical Trials at University of Debrecen


During the past decade, University of Debrecen conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years88221166223300221100221133113333Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
2000-02-01
2003-01-01
Completed
Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
2004-02-01
2007-06-01
Completed
368
Efficacy and Safety of BG00012 in MS
2004-10-01
2006-03-01
Completed
260
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
2005-07-01
2015-12-01
Terminated
269
Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
2005-12-01
2009-01-01
Completed
172
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
2006-02-01
2010-07-01
Completed
42
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
2006-09-20
2017-12-11
Completed
1,276
Zalutumumab in Patients With Non-curable Head and Neck Cancer
2006-11-01
2011-08-01
Completed
286

Rows per page:

1–52 of 52

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Debrecen" #1 sponsor was "University of Debrecen" with 4 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Aires Pharmaceuticals, Inc." with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Johns Hopkins University" with 2 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 40 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Debrecen" #1 collaborator was "Emissary International LLC" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "University of Debrecen" with 2 trials as a collaborator and "Accelovance" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Debrecen: 4University of Debrecen: 4AOP OrphanPharmaceuticals AG: 3AOP OrphanPharmaceuticals AG: 3Aires Pharmaceuticals, Inc.: 2Aires Pharmaceuticals, Inc.: 2Incyte Corporation: 2Incyte Corporation: 2Johns Hopkins University: 2Johns Hopkins University: 2Mayo Clinic: 2Mayo Clinic: 2Medtronic CardiacRhythm and HeartFailure: 2Medtronic CardiacRhythm and HeartFailure: 2Semmelweis UniversityHeart and VascularCenter: 2Semmelweis UniversityHeart and VascularCenter: 2SpectrumPharmaceuticals, Inc: 2SpectrumPharmaceuticals, Inc: 2Actelion: 1Actelion: 1

Created with Highcharts 11.1.0Top CollaboratorsEmissary International LLC: 2Emissary International LLC: 2Genentech, Inc.: 2Genentech, Inc.: 2National Institute ofNeurological Disordersand Stroke (NINDS): 2National Institute ofNeurological Disordersand Stroke (NINDS): 2University of Debrecen: 2University of Debrecen: 2Accelovance: 1Accelovance: 1Apatech, Inc.: 1Apatech, Inc.: 1Canadian Institutes ofHealth Research (CIHR):1Canadian Institutes ofHealth Research (CIHR):1Celgene Corporation: 1Celgene Corporation: 1European Commission: 1European Commission: 1Hospital of Komló: 1Hospital of Komló: 1

Clinical Trials Conditions at University of Debrecen


According to Clinical.Site data, the most researched conditions in "University of Debrecen" are "Polycythemia Vera" (3 trials), "Atrial Fibrillation" (2 trials), "Dermatomyositis" (2 trials), "Multiple Myeloma" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "University of Debrecen" in a lesser frequency.

Clinical Trials Intervention Types at University of Debrecen


Most popular intervention types in "University of Debrecen" are "Drug" (35 trials), "Device" (7 trials), "Other" (6 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (2 trials), "AIR001" (1 trials), "AIR001 (sodium nitrite inhalation solution)" (1 trials) and "Ablation / MRI" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Debrecen


The vast majority of trials in "University of Debrecen" are 48 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at University of Debrecen


Currently, there are 9 active trials in "University of Debrecen". 1 are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in University of Debrecen, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University of Debrecen, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Phase 2: 12Phase 2: 12Not Applicable: 7Not Applicable: 7Phase 4: 3Phase 4: 3Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 38Completed: 38Active, not recruiting: 4Active, not recruiting: 4Recruiting: 3Recruiting: 3Terminated: 3Terminated: 3Unknown status: 2Unknown status: 2Enrolling by invitation: 1Enrolling by invitation: 1Not yet recruiting: 1Not yet recruiting: 1